⚠ LIVE — European Consumer Safety Watch 💊 Medicines: 15 in last 7 days 🍎 Food: 1 in last 7 days 🧸 Products: 52 in last 7 days 🟢 Monitoring: EMA · RASFF · NVWA · FAGG · FAVV · EFSA · Safety Gate ⏱ Last fetch: 2 hours ago ⚠ LIVE — European Consumer Safety Watch 💊 Medicines: 15 in last 7 days 🍎 Food: 1 in last 7 days 🧸 Products: 52 in last 7 days 🟢 Monitoring: EMA · RASFF · NVWA · FAGG · FAVV · EFSA · Safety Gate ⏱ Last fetch: 2 hours ago
🛡️ EUSW
🇬🇧
💊 Medicine EU October 31, 2025

NovoNordisk insulin (human insulin) (various short-, rapid-, intermediate-, mixed- and long-acting forms)

📷 EU Safety Watch placeholder
NovoNordisk insulin (human insulin) (various short-, rapid-, intermediate-, mixed- and long-acting forms)
📷 EU Safety Watch placeholder
Forms
Solution for injection;Suspension for injection
Strengths
100 units/ml
Alternatives
Yes
🗄
Archived (older alert)
This alert was reported 269 days ago and has been moved from our active feed to the archive. The original safety information still applies — we have no confirmation from the issuing agency that the product is safe again. Refer to the official notice for the current status.
📈 Timeline
1 days in total
May 20, 2026 May 21, 2026

What is this? This is human insulin made by NovoNordisk. It comes as a liquid or cloudy mix in a pen or vial. People use it to control blood sugar.

What's happening? Some types of this insulin are hard to find right now in the EU. Supplies are low.

Does this affect me? If you use one of these insulin types, you may have trouble getting your usual supply.

What should I do? Ask your pharmacist or doctor for help finding a replacement or adjusting your dose.

🤖 This plain-language summary is automatically generated from the official agency notice using AI. It is for general information only — not medical advice. For decisions about your health, always consult a pharmacist or doctor and read the official source linked below.

🔬 Medical / technical details (for professionals)
Agency-published detail

Forms: Solution for injection;Suspension for injection · Strengths: 100 units/ml · Alternatives: Yes

First published
October 31, 2025
Last refreshed by us
2 months ago
Severity (as classified)
High
Official source
http://www.ema.europa.eu/en/medicines/human/shortages/novonordisk-insulin-human-insulin-various-short-rapid-intermediate-mixed-long-acting-forms

All information on this page comes from the official agency notice. We translate and summarise it; we don't add or edit facts.

Related alerts

❓ Frequently asked questions

What is this medicine shortage alert about?
NovoNordisk insulin (human insulin) (various short-, rapid-, intermediate-, mixed- and long-acting forms). Forms: Solution for injection;Suspension for injection · Strengths: 100 units/ml · Alternatives: Yes
When was this alert issued?
This alert was issued on October 31, 2025 by EMA (European Medicines Agency).
Which countries are affected?
The alert applies to the entire EU.
How serious is this alert?
Serious risk. A serious risk means the product or medicine can cause significant harm. Treat the alert as urgent.
What should I do?
If you take this medicine, contact your pharmacist or prescribing doctor. They can advise on alternative products or substitutes. Do not stop taking prescription medicine without medical advice.
Where can I find the official notice?
The full official notice is published on www.ema.europa.eu.

💬 Discussion

Share your experience or ask a question. Real names and email are optional but moderation friendly.

No comments yet — be the first.

We email a confirmation link. Your address stays private.

⚠️ We aggregate official notices. We do not give medical advice. For medical or legal decisions, consult the source agency and a qualified professional.